NEW YORK — Investment banks William Blair, Canaccord Genuity, and BTIG on Monday initiated coverage of newly public diagnostics firm Biodesix, with ratings ranging from Buy to Outperform.
NEW YORK — Investment banks William Blair, Canaccord Genuity, and BTIG on Monday initiated coverage of newly public diagnostics firm Biodesix, with ratings ranging from Buy to Outperform.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.